Whole blood transcriptome correlates with treatment response in nasopharyngeal carcinoma

Journal of Experimental and Clinical Cancer Research

Volumn 31, Issue 1, 2012, Pages

  Zaatar, Adel M ^a,b   Lim, Chun Ren ^c   Bong, Chin Wei ^c   Lee, Michelle Mei Lin ^c   Ooi, Jian Jiek ^c   Suria, David ^d   Raman, Rakesh ^a   Chao, Samuel ^d   Yang, Hengxuan ^d   Neoh, Soon Bin ^e   Liew, Choong Chin ^d,f  

^a Mount Miriam Cancer Hospital   (Malaysia)

^b Gleneagles Medical Centre   (Malaysia)

^c GeneNews Malaysia   (Malaysia)

^d GeneNews Limited   (Canada)

^e Lam Wah Ee Hospital   (Malaysia)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Blood; Microarray; Nasopharyngeal carcinoma; Transcriptomics

Indexed keywords

CISPLATIN DERIVATIVE; EDETIC ACID; RNA; TRANSCRIPTOME; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CISPLATIN RESISTANT ASSOCIATED OVEREXPRESSED PROTEIN GENE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; LOW DENSITY LIPOPROTEIN RECEPTOR ADAPTOR PROTEIN 1 GENE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NASOPHARYNX CARCINOMA; PHD FINGER PROTEIN 20 GENE; PRIORITY JOURNAL; RNA ISOLATION; TREATMENT RESPONSE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; ANTIGENS, NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; RNA-BINDING PROTEINS; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84870065511     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-31-76     Document Type: Article

References (27)

1. Ferlay J, Parkin DM, Curado MP, Bray F, Edwards B, Shin HR, Forman D, Cancer Incidence in Five Continents, Volumes I to IX: IARC Cancer Base No. 9 [Internet] International Agency for Research on Cancer, Lyon, France 2010 Available from: http://ci5.iarc.fr
2. National Cancer Registry, Ministry of Health Malaysia, Malaysia Cancer Statistics: Data and Figures Peninsular Malaysia National Cancer Registry, Ministry of Health Malaysia, Kuala Lumpur 2006
3. The human antigen class I genes in nasopharyngeal carcinoma risk. Hassen E, Nahla G, Bouaouina N, Chouchane L, Mol Biol Rep 2010 37 119 126 10.1007/s11033-009-9548-9 19449168
4. Salted fish and inhalants as risk factors for nasopharyngeal carcinoma in Malaysian Chinese. Armstrong RW, Armstrong MJ, Yu MC, Henderson BE, Cancer Res 1983 43 2967 2970 6850606
5. Nasopharyngeal carcinoma. Wei WI, Sham JST, Lancet 2005 365 2041 2054 10.1016/S0140-6736(05)66698-6 15950718
6. Nasopharyngeal carcinoma - review of the molecular mechanisms of tumorigenesis. Chou J, Lin YC, Kim J, You L, Xu Z, He B, Jablons DM, Head Neck 2008 30 946 963 10.1002/hed.20833 18446839
7. Treatment approaches to nasopharyngeal carcinoma: a review. Caponigro F, Longo F, Ionna F, Perri F, Anti-cancer Drugs 2010 21 471 477 10.1097/CAD.0b013e328337160e 20124988
8. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant radiotherapy in patients with American Joint Committee on Cancer/International Union against Cancer Stage III and IV nasopharyngeal cancer of the endemic variety. Wee J, Tan EH, Tai BC, Wong HB, Leong SS, Tan T, Chua ET, Yang E, Lee KM, Fong KW, Tan HS, Lee KS, Loong S, Sethi V, Chua EJ, Machin D, J Clin Oncol 2005 23 6730 6738 10.1200/JCO.2005.16.790 16170180
9. Chemoradiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. Al-Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T, Forastiere AA, Adams G, Sakr WA, Schuller DE, Ensley JF, J Clin Oncol 1998 16 1310 1317 9552031
10. Blood-based biomarker panel for stratifying current risk for colorectal cancer. Marshall KW, Mohr S, Khettabi FE, Nossova N, Chao S, Bao W, Ma J, Li XJ, Liew CC, Int J Cancer 2010 126 1177 1186 19795455
11. Blood gene expression signatures associate with heart failure outcomes. Vanburen P, Ma J, Chao S, Mueller E, Schneider DJ, Liew CC, Physiol Genomics 2011 43 392 397 10.1152/physiolgenomics.00175.2010 21266504
12. Novel blood biomarkers of human urinary bladder cancer. Osman I, Bajorin DF, Sun TT, Zhong H, Douglas D, Scattergood J, Zheng R, Han M, Marshall KW, Liew CC, Clin Cancer Res 2006 12 3374 3380 10.1158/1078-0432.CCR-05-2081 16740760
13. Novel blood-based, five-gene biomarker set for the detection of colorectal cancer. Han M, Liew CT, Zhang HW, Chao S, Zheng R, Yip KT, Song ZY, Li HM, Geng XP, Zhu LX, Lin JJ, Marshall KW, Liew CC, Clin Cancer Res 2008 14 455 460 10.1158/1078-0432.CCR-07-1801 18203981
14. Differential regulation of peripheral leukocyte genes in patients with active Crohn's disease and Crohn's disease in remission. Burakoff R, Hande S, Ma J, Banks PA, Friedman S, Makrauer F, Liew CC, J Clin Gastroenterol 2010 44 120 126 10.1097/MCG.0b013e3181a9ef53 19826276
15. Blood-based biomarkers can differentiate ulcerative colitis from Crohn's disease and noninflammatory diarrhea. Burakoff R, Chao S, Perencevich M, Ying J, Friedman S, Makrauer F, Odze R, Khurana H, Liew CC, Inflamm Bowel Dis 2011 17 1719 1725 10.1002/ibd.21574 21744426
16. Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report. Tsuang MT, Nossova N, Yager T, Tsuang MM, Guo SC, Shyu KG, Glatt SJ, Liew CC, Am J Med Genet B Neuropsychiatr Genet 2005 133B 1 5 10.1002/ajmg.b.30161 15645418
17. Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia. Glatt SJ, Everall IP, Kremen WS, Corbeil J, Sásik R, Khanlou N, Han M, Liew CC, Tsuang MT, Proc Natl Acad Sci U S A 2005 102 15533 15538 10.1073/pnas.0507666102 16223876
18. Similarities and differences in peripheral blood gene-expression signatures of individuals with schizophrenia and their first-degree biological relatives. Glatt SJ, Stone WS, Nossova N, Liew CC, Seidman LJ, Tsuang MT, Am J Med Genet B Neuropsychiatr Genet 2011 156B 869 887 21972136
19. Eight-signature classifier for prediction of nasopharyngeal carcinoma survival. Wang HY, Sun BY, Zhu ZH, Chang ET, To KF, Hwang JS, Jiang H, Kam MK, Chen G, Cheah SL, Lee M, Liu ZW, Chen J, Zhang JX, Zhang HZ, He JH, Chen FL, Zhu XD, Huang MY, Liao DZ, Fu J, Shao Q, Cai MB, Du ZM, Yan LX, Hu CF, Ng HK, Wee JT, Qian CN, Liu Q, Ernberg I, Ye W, Adami HO, Chan AT, Zeng YX, Shao JY, J Clin Oncol 2011 29 4516 4525 10.1200/JCO.2010.33.7741 22025164
20. Amphiregulin is a vitamin D3 target gene in squamous cell and breast carcinoma. Akutsu N, Bastien Y, Lin R, Mader S, White JH, Biochem Biophys Res Commun 2001 281 1051 1056 10.1006/bbrc.2001.4466 11237771
21. Identification of genes associated with non-small-cell lung cancer promotion and progression. Bankovic J, Stojsic J, Jovanovic D, Andjelkovic T, Milinkovic V, Ruzdijic S, Tanic N, Lung Cancer 2010 67 151 159 10.1016/j.lungcan.2009.04.010 19473719
22. Increased seroreactivity to glioma-expressed antigen 2 in brain tumor patients under radiation. Heisel SM, Ketter R, Keller A, Klein V, Pallasch CP, Lenhof HP, Meese E, PLoS One 2008 3 2164 10.1371/journal.pone.0002164 18478111
23. CROP/Luc7A, a novel serine/arginine-rich nuclear protein, isolated from cisplatin-resistant cell line. Nishii Y, Morishima M, Kakehi Y, Umehara K, Kioka N, Terano Y, Amachi T, Ueda K, FEBS Lett 2000 465 153 156 10.1016/S0014- 5793(99)01744-5 10631324
24. Effect of cisplatin treatment on speckled distribution of a serine/arginine-rich nuclear protein CROP/Luc7A. Umehara H, Nishii Y, Morishima M, Kakehi Y, Kioka N, Amachi T, Koizumi J, Hagiwara M, Ueda K, Biochem Biophys Res Commun 2003 301 324 329 10.1016/S0006-291X(02)03017-6 12565863
25. Association of ABCC2 and CDDP-resistance in two sublines resistant to CDDP derived from a human nasopharyngeal carcinoma cell line. Xie SM, Fang WY, Liu TF, Yao KT, Zhong XY, J Oncol 2010 915046 7 10.1155/2010/915046
26. Cisplatin as an Anti-Tumor Drug: Cellular mechanisms of activity, drug resistance and induced side effects. Florea AM, Büsselberg D, Cancers 2011 3 1351 1371 10.3390/cancers3011351
27. B cell signaling and fate decision. Kurosaki T, Shinohara H, Baba Y, Annu Rev Immunol 2010 28 21 55 10.1146/annurev.immunol.021908.132541 19827951